Pieris Pharmaceuticals announces 1-for-80 reverse stock split
PremiumThe FlyPieris Pharmaceuticals announces 1-for-80 reverse stock split
5M ago
Pieris Pharmaceuticals Enacts Reverse Stock Split for NASDAQ Compliance
Premium
Company Announcements
Pieris Pharmaceuticals Enacts Reverse Stock Split for NASDAQ Compliance
5M ago
Pieris Pharmaceuticals sees cash runway into 2027
Premium
The Fly
Pieris Pharmaceuticals sees cash runway into 2027
6M ago
Soleno Therapeutics announces appointments to its leadership team
PremiumThe FlySoleno Therapeutics announces appointments to its leadership team
8M ago
Pieris Pharmaceuticals Inc (PIRS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Pieris Pharmaceuticals Inc (PIRS) Q3 Earnings Cheat Sheet
11M ago
Hansa Biopharma appoints Hitto Kaufmann as chief scientific officer
Premium
The Fly
Hansa Biopharma appoints Hitto Kaufmann as chief scientific officer
1y ago
Pieris Pharmaceuticals announces restructuring, to reduce workforce by 70%
PremiumThe FlyPieris Pharmaceuticals announces restructuring, to reduce workforce by 70%
1y ago
Pieris Pharmaceuticals trading halted, news pending
Premium
The Fly
Pieris Pharmaceuticals trading halted, news pending
1y ago
Pieris Pharmaceuticals Craters after AstraZeneca Halts Clinical Trial
Premium
Market News
Pieris Pharmaceuticals Craters after AstraZeneca Halts Clinical Trial
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100